| William Keith Ballentine Iii, MD | |
|
740 S Limestone Ste B200, Lexington, KY 40536-0001 | |
| (859) 257-3533 | |
| (859) 257-6024 |
| Full Name | William Keith Ballentine Iii |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 13 Years |
| Location | 740 S Limestone Ste B200, Lexington, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982051330 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | TP732 (Kentucky) | Secondary |
| 208800000X | Urology | 219511 (North Carolina) | Secondary |
| 208800000X | Urology | 58626 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kentucky Medical Services Foundation, Inc | 5698689909 | 806 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced that the United States District Court for the Southern District of New York had dismissed in its entirety the complaint filed by Taro Pharmaceutical Industries Ltd. seeking to block the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd., to purchase all outstanding Ordinary Shares of Taro.
Childhood abuse is more common in women with migraine who suffer depression than in women with migraine alone, according to a study published in the September 4, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
Parenting infants and toddlers can be challenging, and for generations, mothers have turned to other moms for advice. Now, with the availability of the Internet, mothers are consulting each other using modern venues: online message boards. Research from the University of Missouri indicates online discussion boards provide safe environments for mothers to anonymously express child-rearing concerns and receive support from other moms.
Stem cell therapy may restore cognition in patients with brain cancer who experience functional learning and memory loss often associated with radiation treatment, according to a laboratory study published in Cancer Research, a journal of the American Association for Cancer Research.
Rigel Pharmaceuticals, Inc. today announced the initiation of a Phase 3 clinical program for its oral SYK inhibitor, fostamatinib, in patients with ITP (immune thrombocytopenic purpura).
› Verified 4 days ago
| Entity Name | University Of Kentucky |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770771974 PECOS PAC ID: 3072425289 Enrollment ID: O20031105000072 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced that the United States District Court for the Southern District of New York had dismissed in its entirety the complaint filed by Taro Pharmaceutical Industries Ltd. seeking to block the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd., to purchase all outstanding Ordinary Shares of Taro.
Childhood abuse is more common in women with migraine who suffer depression than in women with migraine alone, according to a study published in the September 4, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
Parenting infants and toddlers can be challenging, and for generations, mothers have turned to other moms for advice. Now, with the availability of the Internet, mothers are consulting each other using modern venues: online message boards. Research from the University of Missouri indicates online discussion boards provide safe environments for mothers to anonymously express child-rearing concerns and receive support from other moms.
Stem cell therapy may restore cognition in patients with brain cancer who experience functional learning and memory loss often associated with radiation treatment, according to a laboratory study published in Cancer Research, a journal of the American Association for Cancer Research.
Rigel Pharmaceuticals, Inc. today announced the initiation of a Phase 3 clinical program for its oral SYK inhibitor, fostamatinib, in patients with ITP (immune thrombocytopenic purpura).
› Verified 4 days ago
| Entity Name | Kentucky Medical Services Foundation, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326091448 PECOS PAC ID: 5698689909 Enrollment ID: O20031119000300 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced that the United States District Court for the Southern District of New York had dismissed in its entirety the complaint filed by Taro Pharmaceutical Industries Ltd. seeking to block the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd., to purchase all outstanding Ordinary Shares of Taro.
Childhood abuse is more common in women with migraine who suffer depression than in women with migraine alone, according to a study published in the September 4, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
Parenting infants and toddlers can be challenging, and for generations, mothers have turned to other moms for advice. Now, with the availability of the Internet, mothers are consulting each other using modern venues: online message boards. Research from the University of Missouri indicates online discussion boards provide safe environments for mothers to anonymously express child-rearing concerns and receive support from other moms.
Stem cell therapy may restore cognition in patients with brain cancer who experience functional learning and memory loss often associated with radiation treatment, according to a laboratory study published in Cancer Research, a journal of the American Association for Cancer Research.
Rigel Pharmaceuticals, Inc. today announced the initiation of a Phase 3 clinical program for its oral SYK inhibitor, fostamatinib, in patients with ITP (immune thrombocytopenic purpura).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Keith Ballentine Iii, MD 740 S Limestone Ste B200, Lexington, KY 40536-0001 Ph: (859) 257-3533 | William Keith Ballentine Iii, MD 740 S Limestone Ste B200, Lexington, KY 40536-0001 Ph: (859) 257-3533 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced that the United States District Court for the Southern District of New York had dismissed in its entirety the complaint filed by Taro Pharmaceutical Industries Ltd. seeking to block the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd., to purchase all outstanding Ordinary Shares of Taro.
Childhood abuse is more common in women with migraine who suffer depression than in women with migraine alone, according to a study published in the September 4, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
Parenting infants and toddlers can be challenging, and for generations, mothers have turned to other moms for advice. Now, with the availability of the Internet, mothers are consulting each other using modern venues: online message boards. Research from the University of Missouri indicates online discussion boards provide safe environments for mothers to anonymously express child-rearing concerns and receive support from other moms.
Stem cell therapy may restore cognition in patients with brain cancer who experience functional learning and memory loss often associated with radiation treatment, according to a laboratory study published in Cancer Research, a journal of the American Association for Cancer Research.
Rigel Pharmaceuticals, Inc. today announced the initiation of a Phase 3 clinical program for its oral SYK inhibitor, fostamatinib, in patients with ITP (immune thrombocytopenic purpura).
› Verified 4 days ago
Dr. Justin Dale Johnson, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1401 Harrodsburg Rd, Suite C-215, Lexington, KY 40504 Phone: 859-258-6450 Fax: 859-258-6499 | |
Dr. William E Blackburn, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1760 Nicholasville Rd, Suite 301, Lexington, KY 40503 Phone: 859-277-5766 Fax: 859-277-3406 | |
Nadia Gabriela Romero, Urology Medicare: Medicare Enrolled Practice Location: 800 Rose St Rm Mn-283, Lexington, KY 40536 Phone: 859-323-5057 Fax: 859-257-6024 | |
Fred Park Hadley, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1401 Harrodsburg Rd, Ste C215, Lexington, KY 40504 Phone: 859-258-6450 Fax: 859-258-6499 | |
Thomas Kirk Slabaugh Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1401 Harrodsburg Rd, C215, Lexington, KY 40504 Phone: 859-258-6450 Fax: 859-258-6499 | |
Scott Erpelding, Urology Medicare: Accepting Medicare Assignments Practice Location: University Of Kentucky, 800 Rose Street, Room Mn-283, Lexington, KY 40536 Phone: 859-323-5057 Fax: 859-257-6024 | |
Bruce Allan Lucas, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 740 South Limestone, Lexington, KY 40536 Phone: 859-257-3533 |